The covid-19 outbreak has had a significant impact on daily life of populations in the last year. Recently three pharmaceutical companies have communicated promising results of their vaccination candidates against Covid-19. Various countries in Europe have implemented vaccination programs or strategies how to set these up. Within the webinar those programs will be assessed utilizing a Covid-19 SEIR model (CovidSIM). The MArS expert team in conjunction with Mathias Flume, regional German payer, will show and discuss you in the webinar: • Vaccination programs in Europe and especially in Germany • Implication of these programs from a simulation perspective • An estimation of when the "old" normal might be the "new(est)" normal The webinar will be held one week before Christmas. The first 24 registrations will receive a German "Gluehwein" as normally available on German Christmas markets.